Search Results

154 results found

Amending Regulation (EU) No 168/2013 as regards specific measures on L-category end-of-series vehicles in response to the COVID-19 pandemic (A9-0190/2020 - Maria Grapini) [PT]

Work in Parliament | Explanations of Vote | 19-10-2020

A pandemia COVID-19 está a causar graves perturbações que estão a afetar a indústria dos motociclos que, por um lado, interferem imediatamente com os locais de produção e as cadeias de valor internacionais e, por outro lado, provocam uma quebra considerável na procura e um aumento dos veículos em armazém. Tudo isto afetou a capacidade dos fabricantes de cumprir alguns dos prazos impostos pelo Regulamento (UE) n.º 168/2013 do Parlamento Europeu e do Conselho, de 15 de janeiro de 2013. Votei fa...

Webinar "Impact of COVID-19 on older adults with cancer", organised by International Society of Geriatric Oncology (SIOG)

Agenda | 14-10-2020

Implementation of the common commercial policy – annual report 2018 (A9-0160/2020 - Jörgen Warborn) [PT]

Work in Parliament | Explanations of Vote | 07-10-2020

Votei favoravelmente o presente relatório sobre a implementação da Política Comercial Comum, uma competência exclusiva da União que requer que a UE fale a uma só voz em assuntos comerciais, agindo a Comissão como negociadora. O relatório Warborn destaca que a estratégia comercial da UE «Comércio para Todos», adotada em 2015, deve continuar a promover os interesses e valores da União quando enfrenta novos desafios em todo o mundo, aumentar a competitividade da indústria europeia e gerar cresci...

Conference "Recovery Plans in the EU after COVID-19", promoted by the Instituto Francisco Sá Carneiro and the Konrad Adenauer Foundation

Agenda | 02-10-2020

ENVI/ITRE Joint Hearing on "How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges”

Agenda | 22-09-2020

Covid-19: EU coordination of health assessments and risk classification and the consequences on Schengen and the single market (RC-B9-0257/2020) [PT]

Work in Parliament | Explanations of Vote | 17-09-2020

Um dos desafios da presente pandemia são os impactos do surto de COVID-19 e as suas consequências de longo prazo para o bem-estar das pessoas nomeadamente dos grupos mais vulneráveis e das pessoas em situações vulneráveis, como os idosos e as pessoas que já sofrem de problemas de saúde. Uma resposta coordenada não pode passar pelo encerramento das fronteiras internas que tem efeitos nocivos no mercado interno devendo a UE adoptar medidas comuns que permitam restabelecer a confiança entre os ...

Cultural recovery of Europe [PT]

Work in Parliament | Explanations of Vote | 17-09-2020

A cultura é um ativo estratégico para a União Europeia. É importante na nossa economia, reflete os nossos valores comuns europeus e está enraizada nas tradições, na história e no modo de vida dos nossos povos. É fundamental preservar este património comum, respeitando e valorizando a sua diversidade, e são necessárias estratégias que permitam recuperar um setor particularmente afetado pela pandemia de covid-19.

Sustainable rail market in view of COVID-19 outbreak [PT]

Work in Parliament | Explanations of Vote | 17-09-2020

O setor ferroviário tem uma importância estratégica para a União Europeia, contribuindo para o emprego e para a economia global da UE, empregando diretamente mais de um milhão de pessoas, cerca de 600 000 em empresas ferroviárias e 440 000 através de gestores de infraestruturas. A pandemia de COVID-19 provocou uma queda significativa da procura, que levou a uma queda abrupta do transporte ferroviário tendo um grave impacto nas empresas ferroviárias. As circunstâncias estão fora do controlo d...

Maria da Graça Carvalho welcomes the creation of a European Biomedical Research Agency, but asks for funds to match the ambition

Press | Press Releases | 16-09-2020

MEP Maria da Graça Carvalho (EPP) praises the decision to create a European Biomedical Research Agency, announced today by the President of the European Commission, Ursula Von der Leyen, during her State of the Union speech. “The existence of an agency dedicated to scientific research in the health field is something I have been striving for since I was rapporteur for the Horizon 2020 framework program, at the beginning of the last decade”, recalls the MEP. With this announcement, she adds...

Maria da Graça Carvalho welcomes the creation of a European Biomedical Research Agency, but asks for funds to match the ambition

Work in Parliament | Other Activities | 16-09-2020

MEP Maria da Graça Carvalho (EPP) praises the decision to create a European Biomedical Research Agency, announced today by the President of the European Commission, Ursula Von der Leyen, during her State of the Union speech. “The existence of an agency dedicated to scientific research in the health field is something I have been striving for since I was rapporteur for the Horizon 2020 framework program, at the beginning of the last decade”, recalls the MEP. With this announcement, she adds...

Transitional provisions in order to address the impact of COVID-19 crisis (amendment of Regulation (EU) 2016/1628) (C9-0161/2020)

Work in Parliament | Explanations of Vote | 10-07-2020

Disruptions of supply chains resulting from the COVID-19 outbreak were a very general problem that still has direct and indirect consequences on many European industries. The non-road mobile machinery (NRMM) and tractor manufacturers sectors are among them. Generalised factory shutdowns in Europe and the absence of critical components were leaving manufacturers with stocks of engines, unfinished products and risking deadlines set by the relevant regulation not being met. In April I wrote a...

The EU’s public health strategy post-COVID-19 (RC-B9-0216/2020)

Work in Parliament | Explanations of Vote | 10-07-2020

I supported this resolution as it frames the priorities we need for an appropriate strategy on health in light of the Covid crisis. Health must be embedded in all policies, horizontally. To implement this principle, the Union must agree on a strong MFF that includes dedicated funds for health infrastructures. Research and innovation must always be nurtured and promoted, especially when it comes to medical treatments, vaccines, but also rare and neglected diseases. International partnerships...

Please note, your browser is out of date.
For a good browsing experience we recommend using the latest version of Chrome, Firefox, Safari, Opera or Internet Explorer.